Harding Loevner’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-487,113
Closed -$255M 72
2025
Q1
$255M Sell
487,113
-85,292
-15% -$43.6M 1.95% 17
2024
Q4
$290M Buy
572,405
+122,403
+27% +$69.5M 1.96% 18
2024
Q3
$263M Sell
450,002
-11,010
-2% -$6.23M 1.52% 24
2024
Q2
$235M Sell
461,012
-15,158
-3% -$7.43M 1.3% 28
2024
Q1
$236M Sell
476,170
-38,947
-8% -$19.8M 1.45% 28
2023
Q4
$271M Sell
515,117
-9,085
-2% -$4.85M 1.52% 23
2023
Q3
$264M Sell
524,202
-74,192
-12% -$36.5M 1.75% 20
2023
Q2
$288M Sell
598,394
-113,719
-16% -$55.6M 1.68% 21
2023
Q1
$337M Sell
712,113
-5,683
-0.8% -$2.74M 1.92% 17
2022
Q4
$381M Buy
717,796
+74,859
+12% +$39.7M 2.19% 13
2022
Q3
$325M Sell
642,937
-155,035
-19% -$81.5M 2.13% 16
2022
Q2
$410M Sell
797,972
-21,457
-3% -$10.8M 2.53% 11
2022
Q1
$399M Sell
819,429
-68,538
-8% -$33.1M 2.2% 15
2021
Q4
$446M Buy
887,967
+303,705
+52% +$137M 1.71% 20
2021
Q3
$228M Sell
584,262
-20,908
-3% -$8.66M 0.91% 42
2021
Q2
$242M Buy
605,170
+5,168
+0.9% +$2.06M 0.91% 37
2021
Q1
$223M Buy
600,002
+599,891
+540,442% +$208M 0.87% 39
2020
Q4
$39K Sell
111
-22
-17% -$7.37K ﹤0.01% 115
2020
Q3
$41K Sell
133
-13,529
-99% -$4.16M ﹤0.01% 145
2020
Q2
$4.03M Sell
13,662
-222
-2% -$63.6K 0.02% 70
2020
Q1
$3.46M Sell
13,884
-2,479
-15% -$682K 0.02% 75
2019
Q4
$4.81M Buy
16,363
+674
+4% +$176K 0.02% 73
2019
Q3
$3.41M Buy
15,689
+68
+0.4% +$16.4K 0.02% 71
2019
Q2
$3.81M Buy
15,621
+631
+4% +$152K 0.02% 72
2019
Q1
$3.71M Buy
+14,990
New +$3.82M 0.02% 70

Other funds holding UNH

Harding Loevner's UNH Position: Q2 2025 in Review

Harding Loevner sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 487,113 shares — an estimated $255M sold.

Harding Loevner first reported a position in UNH in Q1 2019 and held it in 25 quarters. The position peaked at $446M in Q4 2021. 3,180 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Harding Loevner reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Harding Loevner sold 487,113 UnitedHealth shares in Q2 2025, an estimated $255M.
  • Harding Loevner first reported a position in UnitedHealth in Q1 2019 and held it in 25 quarters.
  • Harding Loevner's UnitedHealth position peaked at $446M in Q4 2021.
  • 3,180 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Harding Loevner's 13F filing for Q2 2025, filed 14 Aug 2025.